Summary
Global Data’s clinical trial report,
Fatty Liver Disease Global Clinical Trials Review, H2, 2013" provides data
on the Fatty Liver Disease clinical trial scenario. This report provides elemental
information and data relating to the clinical trials on Fatty Liver Disease. It
includes an overview of the trial numbers and their recruitment status as per
the site of trial conduction across the globe. The data book offers a
preliminary coverage of disease clinical trials by their phase, trial status,
prominence of the sponsors and also provides briefing pertaining to the number
of trials for the key drugs for treating Fatty Liver Disease. This report is
built using data and information sourced from proprietary databases, primary
and secondary research and in-house analysis by Global Data’s team of industry
experts.
Note: Certain sections in the report
may be removed or altered based on the availability and relevance of data for
the indicated disease.
Scope
* Data on the number of clinical
trials conducted in North America, South and Central America, Europe,
Middle-East and Africa and Asia-pacific and top five national contributions in
each, along with the clinical trial scenario in BRIC nations
* Clinical trial (complete and in
progress) data by phase, trial status, subjects recruited and sponsor type
* Listings of discontinued trials
(suspended, withdrawn and terminated)
Reasons to buy
* Understand the dynamics of a
particular indication in a condensed manner
* Abridged view of the performance
of the trials in terms of their status, recruitment, location, sponsor type and
many more
* Obtain discontinued trial listing
for trials across the globe
* Espy the commercial landscape of
the major Universities / Institutes / Hospitals or Companies
To order this report:
Email: support@researchonglobalmarkets.com
US:
+1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE: Researchonglobalmarkets.com
RELATED LINK:
RELATED VIDEO:
No comments:
Post a Comment